Charleston County Public Library

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Psychometric evaluation and feasibility of the Persian-Relative Mastery Scale in the caregivers.

Authors : Hassani Mehraban, Afsoon; Motaharinezhad, Fatemeh; Ghahari, Setareh

Subjects: MULTIPLE sclerosis treatment; CROSS-sectional method; SCALE analysis (Psychology)IRAN

Source: British Journal of Occupational Therapy; Aug2024, Vol. 87 Issue 8, p504-511, 8p

Record details

Read More Add to Saved list

Academic Journal

Neutrophil to lymphocyte ratio and systemic immune‐inflammatory index as markers of response to autologous hematopoietic stem cell transplantation in persons with multiple sclerosis.

Authors : Ocaña‐Ramm, Guillermo; Gallardo‐Pérez, Moisés Manuel; Garcés‐Eisele, Solón Javier

Subjects: MULTIPLE sclerosis treatment; HEMATOPOIETIC stem cell transplantation; NEUTROPHIL lymphocyte ratio

Source: International Journal of Laboratory Hematology; Aug2024, Vol. 46 Issue 4, p620-626, 7p

Record details

Read More Add to Saved list

Academic Journal

Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisons.

Authors : Paul, Damemarie; Swallow, Elyse; Patterson-Lomba, Oscar

Subjects: MULTIPLE sclerosis treatment; IMMUNOREGULATION; MEDICATION safety

Source: Therapeutic Advances in Neurological Disorders; 6/7/2024, p1-14, 14p

Record details

Read More Add to Saved list

Academic Journal

Blood Flow Restriction and Veterans With Multiple Sclerosis and Advanced Disability: Protocol for a Randomized Controlled Trial.

Authors : Mañago, Mark M.; Will, Robert; Strahler, Talia

Subjects: QUADRICEPS muscle physiology; LEG physiology; MULTIPLE sclerosis treatment

Source: PTJ: Physical Therapy & Rehabilitation Journal; Jun2024, Vol. 104 Issue 6, p1-8, 8p

Record details

Read More Add to Saved list

Academic Journal

TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.

Authors : Kallmann, Boris-Alexander; zu Eulenburg, Georg; Kullmann, Jennifer S.

Subjects: MULTIPLE sclerosis treatment; IMMUNOSUPPRESSIVE agents; PATIENT satisfactionGERMANY

Source: Therapeutic Advances in Neurological Disorders; 5/27/2024, p1-17, 17p

Record details

Read More Add to Saved list

Academic Journal

Intensive Aerobic Cycling Is Feasible and Elicits Improvements in Gait Velocity in Individuals With Multiple Sclerosis: A Preliminary Study.

Authors : Simmons, Sarah B.; Skolaris, Alexis; Love, Ryan

Subjects: MULTIPLE sclerosis treatment; EXERCISE physiology; PATIENT compliance

Source: International Journal of MS Care; May/Jun2024, Vol. 26 Issue 3, p119-124, 6p

Record details

Read More Add to Saved list

Academic Journal

Informing the development of a mobile application for the physical activity guidelines in multiple sclerosis: a qualitative, pluralistic approach.

Authors : Neal, Whitney N.; Richardson, Emma V.; Motl, Robert W.

Subjects: MULTIPLE sclerosis treatment; MOBILE apps; MEDICAL protocols

Source: Disability & Rehabilitation: Assistive Technology; May2024, Vol. 19 Issue 4, p1161-1169, 9p

Record details

Read More Add to Saved list

Academic Journal

Immunotherapeutic potential of dendritic cells in multiple sclerosis.

Authors : LIU Cai-yun; JIN Tao

Subjects: MULTIPLE sclerosis treatment; IMMUNOLOGICAL tolerance; MULTIPLE sclerosis

Source: Chinese Journal of Contemporary Neurology & Neurosurgery; May2024, Vol. 24 Issue 5, p320-330, 11p

Record details

Read More Add to Saved list

Academic Journal

Risks and benefits associated with the primary functions of artificial intelligence powered autoinjectors.

Authors : Machal, Marlon Luca

Subjects: MULTIPLE sclerosis treatment; TREATMENT of diabetes; RHEUMATOID arthritis treatmentUNITED States; UNITED KingdomUNITED States. Food & Drug Administration

Source: Frontiers in Medical Technology; 2024, p1-9, 9p

Record details

Read More Add to Saved list

Academic Journal

Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis – initial results from the observational SISTER study.

Authors : Gold, Ralf; Schmidt, Stephan; Deisenhammer, Florian

Subjects: MULTIPLE sclerosis treatment; NATALIZUMAB; DRUG administration

Source: Therapeutic Advances in Neurological Disorders; 4/13/2024, p1-19, 19p

Record details

Read More Add to Saved list

menu

Search Results

Your Filters

Psychometric evaluation and feasibility of the Persian-Relative Mastery Scale in the caregivers.

Neutrophil to lymphocyte ratio and systemic immune‐inflammatory index as markers of response to autologous hematopoietic stem cell transplantation in persons with multiple sclerosis.

Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisons.

Blood Flow Restriction and Veterans With Multiple Sclerosis and Advanced Disability: Protocol for a Randomized Controlled Trial.

TAURUS-MS II: real-world use of teriflunomide in Germany and changes in treatment patterns over time.

Intensive Aerobic Cycling Is Feasible and Elicits Improvements in Gait Velocity in Individuals With Multiple Sclerosis: A Preliminary Study.

Informing the development of a mobile application for the physical activity guidelines in multiple sclerosis: a qualitative, pluralistic approach.

Immunotherapeutic potential of dendritic cells in multiple sclerosis.

Risks and benefits associated with the primary functions of artificial intelligence powered autoinjectors.

Real-world evidence and patient preference for subcutaneous versus intravenous natalizumab in the treatment of relapsing-remitting multiple sclerosis – initial results from the observational SISTER study.

Contact CCPL

Patron Login

menu

Search Results

Your Filters

Engage with CCPL

Contact CCPL